Merck (MRK) Resubmits NDA for Ezetimibe, Atorvastatin Tabs

January 2, 2013 4:46 PM EST Send to a Friend
Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login